We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 287 results
  1. Post-SARS-CoV-2 Atypical Inflammatory Syndrome in a Toddler with X-Linked Inhibitor of Apoptosis Deficiency After Stem Cell Transplant

    A 10-month-old boy was diagnosed with X-linked lymphoproliferative syndrome type 2 due to X-linked inhibitor of apoptosis deficiency after presenting...

    Prasanth G. Narahari, Jennifer Gebbia, ... Melissa Gans in Journal of Clinical Immunology
    Article 11 July 2022
  2. Identification of Germline Non-coding Deletions in XIAP Gene Causing XIAP Deficiency Reveals a Key Promoter Sequence

    Purpose

    X-linked inhibitor of apoptosis protein (XIAP) deficiency, also known as the X-linked lymphoproliferative syndrome of type 2 (XLP-2), is a...

    Zineb Sbihi, Kay Tanita, ... Sylvain Latour in Journal of Clinical Immunology
    Article 09 January 2022
  3. Single-Cell Transcriptomic Analysis of Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis

    Epstein-Barr virus (EBV) infection can lead to infectious mononucleosis (EBV-IM) and, more rarely, EBV-associated hemophagocytic lymphohistiocytosis...

    Takako Suzuki, Yoshitaka Sato, ... Jun-ichi Kawada in Journal of Clinical Immunology
    Article 20 April 2024
  4. Inborn Errors of Immunity—the Sri Lankan Experience 2010–2022

    Purpose

    Inborn errors of immunity (IEI) are typically monogenic. Data from the Indian subcontinent are relatively scarce. This paper evaluates IEI...

    Dhanushka Dasanayake, Jacinta Bustamante, ... Rajiva de Silva in Journal of Clinical Immunology
    Article 22 July 2023
  5. Molecular Mechanisms of Severe Diseases Caused by Epstein-Barr Virus Infection

    Purpose of Review

    Epstein-Barr virus (EBV) is a ubiquitous virus that infects > 90% of individuals. EBV has been linked to severe conditions such as...

    Article 13 September 2023
  6. HLH and Recurrent EBV Lymphoma as the presenting manifestation of MAGT1 Deficiency: A Systematic Review of the Expanding Disease Spectrum

    Magnesium transporter 1 (MAGT1) gene loss-of-function variants lead to X-linked MAGT1 deficiency with increased susceptibility to EBV infection and...

    Klevi Golloshi, William Mitchell, ... Shanmuganathan Chandrakasan in Journal of Clinical Immunology
    Article 19 June 2024
  7. Molecular Genetics Diversity of Primary Hemophagocytic Lymphohistiocytosis among Polish Pediatric Patients

    Hemophagocytic lymphohistiocytosis (HLH) is a clinical syndrome of life-threatening inflammation caused by an excessive, prolonged and ineffective...

    Katarzyna Bąbol-Pokora, Magdalena Wołowiec, ... Iwona Malinowska in Archivum Immunologiae et Therapiae Experimentalis
    Article Open access 22 October 2021
  8. Allogeneic Hematopoietic cell Transplantation Using Alemtuzumab in Asian Patients with Inborn Errors of Immunity

    Alemtuzumab is used with reduced-toxicity conditioning (RTC) in allogeneic hematopoietic cell transplantation (HCT), demonstrating efficacy and...

    Satoshi Miyamoto, Daiki Niizato, ... Hirokazu Kanegane in Journal of Clinical Immunology
    Article 22 May 2024
  9. Non-osteopenic Bone Pathology After Allo-hematopoietic Stem Cell Transplantation in Patients with Inborn Errors of Immunity

    Purpose

    There is a lack of data on post-HSCT non-osteopenic bone pathology specifically for children with inborn errors of immunity (IEI). We...

    Zainab M. Golwala, Nikita Gireesh Bhat, ... Reem Elfeky in Journal of Clinical Immunology
    Article Open access 17 March 2023
  10. Malignancies in Inborn Errors of Immunity

    Inborn errors of immunity (IEI), also known as primary immunodeficiencies (PIDs), are heterogeneous group of genetic disorders with various clinical...
    Yesim Yilmaz Demirdag, Sudhir Gupta in Cancer Research: An Interdisciplinary Approach
    Chapter 2022
  11. The paradigm of hematological malignant versus non-malignant manifestations, driven by primary immunodeficiencies: a complex interplay

    Hematological malignancies (HM) developed on underlying primary immunodeficiencies (PID) are rare and of unusual features. Differentiating between...

    C. Kelaidi, V. Tzotzola, S. Polychronopoulou in Familial Cancer
    Article 15 June 2021
  12. Letter D

    Dalziel’s syndrome (Dalziel’s disease)“I have pleasure in drawing your attention to this condition, which, I think, has not yet been fully...
    Michael R. Shurin, Galina V. Shurin, Ken M. Shurin in Basic and Clinical Immunology by Names
    Chapter 2023
  13. Autoinflammatory Syndromes

    Autoinflammatory diseases consist of a wide variety of immune-mediated processes. The telltale signature of these processes is compromised innate...
    James M. Fernandez, John McDonnell, Christine A. Royer in Primary and Secondary Immunodeficiency
    Chapter 2021
  14. Identification of a novel nonsense mutation in SH2D1A in a patient with X-linked lymphoproliferative syndrome type 1: a case report

    Background

    X-linked lymphoproliferative syndrome type 1 (XLP1) is an X-linked recessive genetic disorder with a strong resemblance to hemophagocytic...

    Article Open access 12 April 2018
  15. Vaccination for Patients with Inborn Errors of Immunity: a Nationwide Survey in Japan

    We conducted a nationwide survey of inborn errors of immunity (IEI) in Japan for the second time in 10 years, focusing on protective measures for IEI...

    Sho Hosaka, Takahiro Kido, ... Hidetoshi Takada in Journal of Clinical Immunology
    Article 27 October 2021
  16. Experience with a Reduced Toxicity Allogeneic Transplant Regimen for Non-CGD Primary Immune Deficiencies Requiring Myeloablation

    Purpose

    A need exists for reduced toxicity conditioning regimens that offer less toxicity while maintaining myeloablation, especially for primary...

    Sharat Chandra, Shanmuganathan Chandrakasan, ... Rebecca A. Marsh in Journal of Clinical Immunology
    Article 16 October 2020
  17. Ensuring a future for gene therapy for rare diseases

    Alessandro Aiuti, Francesca Pasinelli, Luigi Naldini in Nature Medicine
    Article 15 August 2022
  18. Haploidentical Hematopoietic Stem Cell Transplantation for XIAP Deficiency: a Single-Center Report

    Purpose

    X-linked inhibitor of apoptosis (XIAP) deficiency caused by mutations in the XIAP/BIRC4 gene is a rare inherited primary immunodeficiency also...

    Jun Yang, Guang-Hua Zhu, ... Mao-Quan Qin in Journal of Clinical Immunology
    Article 05 July 2020
Did you find what you were looking for? Share feedback.